Order results by:
| Issue | Title | |
| Vol 14, No 6 (2018) | Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice | Abstract PDF (Eng) similar documents |
| K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova | ||
| "... .9%) – pernanent. Results. While assessing the risk of thromboembolic complications on the CHA2DS2-VASc scale ..." | ||
| Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
| A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
| "... of AF. CHA2DS2-VASc score was used in all patients for calculation the risk of ischemic stroke ..." | ||
| Vol 14, No 5 (2018) | Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin | ||
| "... observation of patients 75 years and older with very high thromboembolic risk (CHA2DS2-VASc – 4,5 points ..." | ||
| Vol 17, No 2 (2021) | Dynamics of Kidney Function in Patients with Chronic Kidney Disease and Atrial Fibrillation Who Receive Dabigatran | Abstract PDF (Eng) similar documents |
| N. A. Novikova, Z. K. Salpagarova, M. I. Chashkina, A. A. Bykova, Z. A. Alimova, А. S. Yadykina, D. F. Mesitskaya, N. A. Babakova, D. A. Andreev | ||
| "... .8, and CHA2DS2VASc score - 3.8. During the observation period, there were 3 cases of major bleeding and 133 ..." | ||
| Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract similar documents |
| V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
| "... Aim. To study the frequency of administration of direct oral anticoagulant (DOACs) in doses ..." | ||
| Vol 13, No 2 (2017) | ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC | Abstract PDF (Eng) similar documents |
| E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov | ||
| "... .6), CHA2DS2-VASc and HAS-BLED score were estimated as 5.14Ѓ}1.50 и 1.59Ѓ}0.79, respectively ..." | ||
| Vol 17, No 6 (2021) | Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020 | Abstract similar documents |
| A. S. Gerasimenko, O. V. Shatalova, V. S. Gorbatenko, V. I. Petrov | ||
| "... included 263 case histories in 2012, 502 ones in 2016 and 524 in 2020. CHA2DS2-VASc score was used ..." | ||
| Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
| E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
| "... fibrillation (AF) was analyzed with CHA2-DS2-VASc score. Results. Appearance of recommendations for the direct ..." | ||
| Vol 15, No 1 (2019) | Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
| "... was performed. Results. All patients were stratified in three groups depending on the CHA2DS2-VASc score ..." | ||
| Vol 17, No 3 (2021) | Treatment and Secondary Prevention of Venous Thromboembolism in Real Clinical Practice Based on Health Care Professional Survey | Abstract similar documents |
| K. V. Lobastov, A. R. Navasardyan, I. V. Schastlivtsev | ||
| "... Aim. To assess the duration of the anticoagulant treatment of venous thromboembolism (VTE ..." | ||
| Vol 5, No 3 (2009) | SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS | Abstract similar documents |
| E. S. Kropacheva | ||
| "... The safety of anticoagulant therapy is discussed. Warfarin position in prevention of thrombotic ..." | ||
| Vol 17, No 2 (2021) | Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic | Abstract similar documents |
| S. M. Mamatov, B. Kanat kyzy, A. O. Musakeev, N. K. Kinderbaeva, T. J. Tagaev | ||
| "... Aim. To study the current state of the anticoagulant's prescription in elderly and senile patients ..." | ||
| Vol 18, No 1 (2022) | Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice | Abstract similar documents |
| Yu. P. Skirdenko, N. A. Nikolaev, K. G. Pereverzeva, A. Yu. Timakova, A. S. Galus, S. S. Yakushin | ||
| "... Aim. To assess the adherence of doctors and patients to anticoagulant therapy for atrial ..." | ||
| Vol 12, No 3 (2016) | THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE | Abstract PDF (Eng) similar documents |
| A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko | ||
| "... according to CHA2DS2-VASc points amount but it did not reach the statistical significance (r=0.620, p=0 ..." | ||
| Vol 15, No 1 (2019) | Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City | Abstract similar documents |
| A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich | ||
| "... patients had an assessment of the risk of thromboembolic complications on the CHA2DS2-VASc scale, the risk ..." | ||
| Vol 12, No 4 (2016) | The use of oral anticoagulants in patients with atrial fibrillation: cohort study data | Abstract similar documents |
| O. V. Gaisenok, A. S. Leonov | ||
| "... Aim. To study the rate of prescription of oral anticoagulants (OAC) in patients with atrial ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... Aim. To assess the compliance of nephroprotective and anticoagulant therapy in patients ..." | ||
| Vol 15, No 3 (2019) | Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation | Abstract similar documents |
| L. N. Uddin, A. V. Egorov, A. A. Sokolova, N. S. Morozova, D. A. Napalkov, V. V. Fomin | ||
| "... men and 75 women) who received anticoagulant therapy (ACT) and underwent planned surgery was carried ..." | ||
| Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Eng) similar documents |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
| "... Aim. To study the structure and incidence of the in-hospital anticoagulants prescription ..." | ||
| Vol 14, No 4 (2018) | Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing | Abstract similar documents |
| A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik | ||
| "... Background. Anticoagulants (AC) are the high-risk drugs. Their safety closely depends on physician ..." | ||
| Vol 14, No 6 (2018) | Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem | Abstract PDF (Eng) similar documents |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| "... The review focuses on the use of oral anticoagulants in fragile elderly patients. The issues ..." | ||
| Vol 7, No 4 (2011) | LEFT VENTRICULAR CLOT LYSIS DUE TO COMBINED ANTICOAGULANT THERAPY WITH WARFARIN AND FRAXIPARINE IN PATIENT WITH DILATED CARDIOMYOPATHY AND CHRONIC HEART FAILURE. THE CLINICAL CASE | Abstract similar documents |
| O. V. Uskova, K. O. Sobolev, G. E. Gendlin, A. V. Melekhov | ||
| "... anticoagulant therapy with warfarin and fraxiparine in patient with dilated cardiomyopathy, congestive heart ..." | ||
| Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
| O. V. Averkov, L. N. Mishchenko | ||
| "... Oral anticoagulant therapy is widely used in different patients for the prevention and treatment ..." | ||
| Vol 10, No 4 (2014) | MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| E. A. Belikov, K. V. Davtyan, O. N. Tkacheva | ||
| "... anticoagulants. ..." | ||
| Vol 9, No 3 (2013) | ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT | Abstract similar documents |
| E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts | ||
| "... are presented. Peculiarities of anticoagulant therapy to prevent thromboembolic complications, the difficulties ..." | ||
| Vol 19, No 3 (2023) | Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report | Abstract similar documents |
| A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov | ||
| "... The question of the safety of direct oral anticoagulants (DOACs), despite their high efficacy ..." | ||
| Vol 17, No 2 (2021) | Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage | Abstract similar documents |
| A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov | ||
| "... Intracerebral hemorrhage (ICH) is severe and fatal complication of anticoagulant therapy ..." | ||
| Vol 8, No 5 (2012) | RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE | Abstract similar documents |
| I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman | ||
| "... with the CHADS2 and CHA2DS2–VASc scales and appointed ATT was analyzed. Results. Patients with high risk of TEC ..." | ||
| Vol 10, No 4 (2014) | FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW | Abstract similar documents |
| S. A. Zenin, A. V. Fedoseenko, O. V. Kononenko, O. V. Pyataeva | ||
| "... base and analysis of complications of different anticoagulants use for safety of sinus rhythm ..." | ||
| Vol 19, No 2 (2023) | Evolution of CHA2DS2-VASc Score for Predicting Risk of Stroke Development in Patients with Atrial Fibrillation | Abstract similar documents |
| A. O. Rubanenko | ||
| "... scores that predict stroke risk,butthe most popular is CHA2DS2-VASc risk score. At the same time ..." | ||
| Vol 16, No 5 (2020) | Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov | ||
| "... to patients with CHA2DS2-VASc=0. In patients with CHA2DS2-VASc=1, a low percentage of anticoagulants ..." | ||
| Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
| A. I. Kochetkov, O. D. Ostroumova | ||
| "... of direct oral anticoagulants (DOACs) compared with vitamin K antagonists due to the extensive body ..." | ||
| Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
| S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova | ||
| "... A recently published article [1 ] on the problems of anticoagulant therapy in patients ..." | ||
| Vol 15, No 4 (2019) | Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... The article discusses issues related to the prescription of anticoagulant therapy to elderly ..." | ||
| Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
| "... . In addition, they emphasize the role of anticoagulant therapy as a preventing tool for the development ..." | ||
| Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
| Sergey N. Bel'diev, Irina V. Medvedeva, Dmitry Yu. Platonov, Galina Yu. Trufanova | ||
| "... ) on the problems of anticoagulant therapy in patients with frailty syndrome contains two statements which highlight ..." | ||
| Vol 18, No 6 (2022) | Perioperative Management of Patients Receiving Antithrombotic Therapy in Schemes and Algorithms | Abstract similar documents |
| O. N. Dzhioeva, E. A. Rogozhkina, O. M. Drapkina | ||
| "... of antiplatelet and/or anticoagulant drugs is a complicating factor in invasive and surgical procedures ..." | ||
| Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
| M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... groups were comparable in risk score by CHA2DS2-VASc and HAS-BLED scales. Results. Patients with AF (n ..." | ||
| Vol 16, No 2 (2020) | Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function | Abstract similar documents |
| N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko | ||
| "... are at high risk of stroke. The direct oral anticoagulants are indicated for them. The choice of a drug should ..." | ||
| Vol 16, No 1 (2020) | Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) | Abstract similar documents |
| N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva | ||
| "... belongs to the number of popular anticoagulants which along with its efficiency not infrequently alters ..." | ||
| Vol 17, No 4 (2021) | Effect of Direct Oral Anticoagulants for Ulcer Epithelization and Laser Doppler Flowmetry Parameters In Patients with Diabetic Foot Syndrome and Atrial Fibrillation | Abstract similar documents |
| V. I. Petrov, N. V. Rogova, T. N. Кuzmina, A. S. Lishuta | ||
| "... therapy with the addition of direct oral anticoagulants (DOAC). Material and methods. An open-label ..." | ||
| Vol 12, No 5 (2016) | Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
| I. S. Daabul, A. A. Sokolova, D. A. Napalkov | ||
| "... with anticoagulants to prevent an ischemic stroke and systemic thromboembolisms. However, in case of combination AF ..." | ||
| Vol 19, No 1 (2023) | Value of Safety of Anticoagulant Therapy in Elderly Patient with Atrial Fibrillation and High Risk of Bleeding | Abstract similar documents |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| "... The review article discusses the safety issue of anticoagulant therapy in elderly patients ..." | ||
| Vol 12, No 2 (2016) | ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, A. V. Rodionov | ||
| "... коронарных артериях. Обсуждаются особенности антитромботической терапии в ранний (стационарный) и в ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... The choice of anticoagulant therapy in patients with atrial fibrillation (AF) and concomitant ..." | ||
| Vol 12, No 4 (2016) | Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation | Abstract similar documents |
| S. G. Kanorskii | ||
| "... , 329 days. The mean CHADS2 and CHA2DS2-VASc scores were 2.0 and 3.4, respectively. Treatmentemergent ..." | ||
| Vol 19, No 2 (2023) | Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative? | Abstract similar documents |
| I. A. Zaigraev, I. S. Yavelov, O. M. Drapkina, E. V. Bazaeva | ||
| "... randomly selected from this database. CHADS2, CHA2DS2-VASc, R2CHADS2, R-CHA2DS2-VASc, R2CHA2DS2-VASc, CHA2 ..." | ||
| Vol 7, No 5 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES | Abstract similar documents |
| Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy | ||
| "... Освещены современные данные и перспективы антитромботической терапии у больных фибрилляцией ..." | ||
| Vol 14, No 1 (2018) | UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME | Abstract similar documents |
| O. V. Krikunova, R. I. Stryuk | ||
| "... Anticoagulant therapy is widely used in all forms of acute coronary syndrome (ACS) to inhibit ..." | ||
| Vol 10, No 2 (2014) | ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, A. S. Maslakov | ||
| "... were stratified into three groups depending on the value of the index CHA2DS2-VASc. Antithrombotic ..." | ||
| Vol 14, No 1 (2018) | THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES | Abstract similar documents |
| M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, T. A. Gomova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, M. A. Bichurina, L. A. Matskevich, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. D. Deev, O. M. Drapkina, s. A. Boytsov | ||
| "... in patients with atrial fibrillation (AF) receiving anticoagulant therapy with warfarin. Material and methods ..." | ||
| Vol 16, No 5 (2020) | Doctors’ Adherence to the Guidelines on the Oral Anticoagulants Usage | Abstract similar documents |
| N. B. Perepech, I. E. Mikhailova, A. V. Tregubov | ||
| "... Aim. To study doctors’ knowledge of the clinical guidelines on the use of oral anticoagulants ..." | ||
| Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
| "... Aim. To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow ..." | ||
| Vol 14, No 1 (2018) | NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| Ju. P. Skirdenko, N. A. Nikolayev | ||
| "... as predictors of choice of optimal anticoagulant therapy in patients with atrial fibrillation (AF). Material ..." | ||
| Vol 18, No 5 (2022) | Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova | ||
| "... The last decade has dramatically changed the strategy of anticoagulant therapy in patients ..." | ||
| Vol 17, No 2 (2021) | Laboratory predictors of clinical outcomes in patients with atrial fibrillation | Abstract similar documents |
| A. A. Sokolova, I. V. Goncharova, A. A. Vedernikov, N. S. Morozova, D. A. Napalkov | ||
| "... positively correlate with the CHA2DS2 and CHA2DS2-VASC scales of stroke risk stratification. The analysis ..." | ||
| Vol 14, No 4 (2018) | Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice | Abstract similar documents |
| N. M. Vorobyeva, O. N. kacheva | ||
| "... of anticoagulants in real clinical practice and questions of adherence of patients to anticoagulant therapy ..." | ||
| Vol 13, No 6 (2017) | PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS | Abstract similar documents |
| A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin | ||
| "... the development of bleeding during anticoagulant therapy with direct oral anticoagulants (DOAC). Material ..." | ||
| Vol 14, No 5 (2018) | Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... . The high risk according to CHA2DS2-VASc scale was revealed in 96.3% of patients and according to HAS-BLED ..." | ||
| Vol 14, No 3 (2018) | THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE | Abstract similar documents |
| I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... long-term anticoagulant therapy with apixaban in a full dose (5 mg b.i.d.), and the patient ..." | ||
| Vol 17, No 1 (2021) | Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction | Abstract similar documents |
| Z. D. Kobalava, A. A. Shavarov, M. V. Vatsik-Gorodetskaya | ||
| "... anticoagulant has unique pharmacologic properties of which clinician should be aware to optimally manage ..." | ||
| Vol 16, No 2 (2020) | The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment | Abstract similar documents |
| К. V. Lobastov, I. V. Schastlivtsev | ||
| "... (VTE) in cancer patients. In accordance with actual guidelines, the duration of anticoagulant therapy ..." | ||
| Vol 7, No 1 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS | Abstract similar documents |
| M. Yu. Gilyarov, V. A. Sulimov | ||
| "... Освещены новые данные и перспективы антитромботической терапии у пациентов с фибрилляцией ..." | ||
| Vol 16, No 5 (2020) | Clinical Case of Complicated Thrombophilia in a Patient with Ulcerative Colitis | Abstract similar documents |
| S. A. Boldueva, I. V. Yarmosh, A. N. Dolinova, Z. G. Kaloeva, M. Yu. Serkova, V. M. Avramova | ||
| "... was continued. At the same time, anticoagulant therapy was started, and antibiotics were canceled. As a result ..." | ||
| Vol 19, No 5 (2023) | Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants | Abstract similar documents |
| M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina | ||
| "... ) in patients receiving continuous direct oral anticoagulant (DOAC) therapy. Material and methods. Data from ..." | ||
| Vol 13, No 5 (2017) | ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT | Abstract similar documents |
| S. G. Kanorskii | ||
| "... Atrial fibrillation (AF) increases the risk of stroke, therefore long-term anticoagulant therapy ..." | ||
| Vol 12, No 5 (2016) | Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms | Abstract PDF (Eng) similar documents |
| Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev | ||
| "... level of adherence compared to patients without anticoagulants (65.2±19.3% vs 68.5±19.1%; Wald-Wolfowitz ..." | ||
| Vol 15, No 5 (2019) | Comparative Analysis of Factors Affecting the Prognosis of Patients with Atrial Fibrillation According to the Results of the REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... points on the CHA2DS2VASc scale – 67.0% and 91.7%, heart rate >90/min – 68.8% and 100% of patients ..." | ||
| Vol 21, No 1 (2025) | Practical aspects of perioperative management in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants | Abstract similar documents |
| E. N. Markova, T. Yu. Vedenikin, A. A. Kuzub, N. V. Kuchieva, A. R. Navasardyan, O. N. Dzhioeva | ||
| "... fibrillation (AF) receiving direct oral anticoagulants (DOACs) and undergoing elective surgical interventions ..." | ||
| Vol 17, No 1 (2021) | Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation | Abstract PDF (Eng) similar documents |
| V. A. Brazhnik, L. O. Minushkina, A. D. Erlikh, E. D. Kosmacheva, M. A. Chichkova, N. R. Khasanov, D. A. Zateyshchikov | ||
| "... in patients with acute coronary syndrome (ACS) undergoing anticoagulants for atrial fibrillation using ..." | ||
| Vol 13, No 4 (2017) | PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) | Abstract similar documents |
| M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov | ||
| "... %, and 29%, respectively. The risk score according to the CHA2DS2-VASc and HAS-BLED scales was higher ..." | ||
| Vol 13, No 1 (2017) | ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY | Abstract similar documents |
| E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
| "... Current guidelines for the management of atrial fibrillation (AF) recommend using anticoagulants ..." | ||
| Vol 20, No 4 (2024) | Clinical application of clinical decision support systems in the management of patients with atrial fibrillation | Abstract similar documents |
| A. V. Ponomarenko, A. D. Gavrilko, A. A. Gartung, M. S. Poliakova, A. A. Oganesyan, K. S. Benimetskaya, D. V. Losik, S. V. Shalaev | ||
| "... of the correct choice of anticoagulant therapy remains relevant in clinical practice. In addition, despite ..." | ||
| Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
| A. V. Rudakova | ||
| "... oral anticoagulants (NOACs). Material and methods. Cost-effectiveness analysis was performed using ..." | ||
| Vol 16, No 6 (2020) | An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? | Abstract similar documents |
| T. V. Pavlova | ||
| "... Anticoagulant therapy in elderly patients with atrial fibrillation and concomitant diseases ..." | ||
| Vol 8, No 4 (2012) | THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY | Abstract similar documents |
| M. Yu. Gilyarov | ||
| Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..." | ||
| Vol 10, No 3 (2014) | COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Rudakova, V. A. Parfenov | ||
| "... fibrillation (NVAF) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin ..." | ||
| Vol 9, No 2 (2013) | ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS | Abstract similar documents |
| O. V. Shatalova, O. N. Smuseva, A. S. Maslakov | ||
| "... accounted for by indirect- acting anticoagulating agents — 66.7% (12/18), direct-acting anticoagulants — 22 ..." | ||
| Vol 10, No 3 (2014) | PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD | Abstract similar documents |
| L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko | ||
| "... , unfortunately, did not lead to wider and more efficient use of anticoagulation therapy. New oral anticoagulants ..." | ||
| Vol 11, No 6 (2015) | PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD | Abstract similar documents |
| L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko | ||
| "... , unfortunately, did not lead to wider and more efficient use of anticoagulation therapy. New oral anticoagulants ..." | ||
| Vol 5, No 1 (2009) | CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY | Abstract similar documents |
| Yu. A. Bunin | ||
| "... stratification) of different antiarrhythmic drugs and anticoagulants are described. Perspectives in improvement ..." | ||
| Vol 16, No 2 (2020) | Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation | Abstract similar documents |
| Yu. P. Skirdenko, N. A. Nikolaev | ||
| "... Aim. To evaluate the effectiveness of the anticoagulant choice algorithm in the prevention ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... by means of the CHA2DS2-VASc score and HAS-BLED score, respectively. Presence of comorbid diseases ..." | ||
| Vol 14, No 6 (2018) | Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding | Abstract PDF (Eng) similar documents |
| A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin | ||
| "... anticoagulants (DOACs) inhibitors, as antidotes for DOAC when stopping life-threatening bleeding. DOAC therapy ..." | ||
| Vol 2, No 3 (2006) | EFFICACY OF THERAPY WITH INDIRECT ANTICOAGULANTS: ROLE OF THE FOODSTUFF VITAMIN K CONTENTS | Abstract similar documents |
| A. P. Momot, O. V. Bespalova, E. N. Vorobyova | ||
| "... The anticoagulants of indirect action during many years serve drugs of basic prophylaxis ..." | ||
| Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
| O. D. Ostroumova, I. V. Goloborodova | ||
| "... and quality of life of the patient. Anticoagulants, widely used in the treatment of thromboembolic ..." | ||
| Vol 10, No 6 (2014) | THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY | Abstract similar documents |
| A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev | ||
| "... for anticoagulant prevention. Besides, heparin and warfarin use for VTE prevention in cancer is accompanied by some ..." | ||
| Vol 15, No 5 (2019) | Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov | ||
| "... Direct oral anticoagulants (not vitamin K antagonists), unlike standard oral anticoagulants (e ..." | ||
| Vol 12, No 5 (2016) | The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin | Abstract similar documents |
| I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich | ||
| "... Цель. Изучить влияние терапии ривароксабаном на частоту развития кардиоэмболических инсультов и ..." | ||
| Vol 10, No 6 (2014) | THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER | Abstract similar documents |
| S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina | ||
| "... Aim. To study in the PROFILE register the rate of new oral anticoagulants (NOAC) taking ..." | ||
| Vol 19, No 3 (2023) | Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants | Abstract similar documents |
| S. R. Gilyarevsky, N. K. Vereina, M. V. Golshmid | ||
| "... to improve the tactics of using direct oral anticoagulants (DOACs) therapy. Clinical situations in which ..." | ||
| Vol 12, No 3 (2016) | THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT | Abstract PDF (Eng) similar documents |
| S. R. Gilyarevskiy | ||
| "... , as well as the choice of anticoagulants, including new oral anticoagulants (NOAC). EINSTEIN-PE is the only ..." | ||
| Vol 19, No 2 (2023) | Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment | Abstract similar documents |
| O. R. Eshmatov, M. S. Khlynin, R. E. Batalov, E. A. Archakov, I. V. Kisteneva | ||
| "... , the incidence of ischemic stroke against the background of anticoagulant therapy and effective catheter ..." | ||
| Vol 11, No 6 (2015) | Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events | Abstract similar documents |
| O. V. Shatalova | ||
| "... терапией у больных с венозными тромбоэмболическими осложнениями (ВТЭО). Материал и методы. Экономическая ..." | ||
| Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract similar documents |
| A. V. Panov | ||
| "... therapy (TAT), selection of P2Y12 inhibitor, choice of oral anticoagulant to be combined with antiplatelet ..." | ||
| Vol 15, No 1 (2019) | Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality? | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... and anticoagulant drugs. Medicine from the very beginning was intended to be personalized, but until recently ..." | ||
| Vol 14, No 2 (2018) | NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov | ||
| "... ) showed that new direct oral anticoagulants (DOACs) were just as effective at preventing stroke ..." | ||
| Vol 18, No 2 (2022) | Antithrombotic Therapy and the Nearest Forecast of Pulmonary Embolism in Rutine Clinical Practice (Data of the Regional Vascular Center of the Ryazan Region) | Abstract similar documents |
| N. N. Nikulina, Yu. V. Terekhovskaya, S. S. Yakushin | ||
| "... manifestations. Anticoagulant therapy was used in 94.2% of cases, of which 90.3% of patients used parenteral ..." | ||
| Vol 14, No 2 (2018) | WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY | Abstract similar documents |
| R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin | ||
| "... duration was 7.6Ѓ}2.0 years. The average score of CHA2DS2-VASc was 3.4Ѓ}1.4. Results. Less than 70 ..." | ||
| 1 - 100 of 1115 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
